0001562180-23-007547.txt : 20231103
0001562180-23-007547.hdr.sgml : 20231103
20231103160710
ACCESSION NUMBER: 0001562180-23-007547
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231102
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hardy Nathan
CENTRAL INDEX KEY: 0001830053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 231376362
MAIL ADDRESS:
STREET 1: C/O SANA BIOTECHNOLOGY, INC.
STREET 2: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-11-02
false
0001770121
Sana Biotechnology, Inc.
SANA
0001830053
Hardy Nathan
C/O SANA BIOTECHNOLOGY, INC.
188 EAST BLAINE STREET, SUITE 400
SEATTLE
WA
98102
false
true
false
false
EVP, Chief Financial Officer
false
Restricted Stock Units
2023-11-02
4
A
false
10000.00
0.00
A
Common Stock
10000.00
10000.00
D
Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
The restricted stock units will vest in full on January 2, 2025, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.
/s/ Julie Shah, Attorney-in-Fact for Nathan Hardy
2023-11-03